Phoenix A Ho

Summary

Affiliation: Fred Hutchinson Cancer Research Center
Country: USA

Publications

  1. pmc High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: a report from the children's oncology group
    Phoenix A Ho
    Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98103, USA
    Br J Haematol 162:670-7. 2013
  2. pmc Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group
    Phoenix A Ho
    Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109, USA
    Blood 113:6558-66. 2009
  3. pmc Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric and adult AML: a report from the Children's Oncology Group and SWOG
    Phoenix A Ho
    Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Blood 118:4561-6. 2011
  4. pmc Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: a report from the Children's Oncology Group
    Phoenix A Ho
    Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Pediatr Blood Cancer 57:204-9. 2011
  5. pmc WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric acute myeloid leukemia: a report from the children's oncology group
    Phoenix A Ho
    Fred Hutchinson Cancer Research Center, D2 373, 1100 Fairview Ave N, Seattle, WA 98103, USA
    J Clin Oncol 29:704-11. 2011
  6. pmc Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group
    Phoenix A Ho
    Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Blood 116:702-10. 2010
  7. doi request reprint The prognostic effect of high diagnostic WT1 gene expression in pediatric AML depends on WT1 SNP rs16754 status: report from the Children's Oncology Group
    Phoenix A Ho
    Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington Division of Pediatric Hematology Oncology, Seattle Children s Hospital, University of Washington School of Medicine, Seattle, Washington Children s Oncology Group, Arcadia, California
    Pediatr Blood Cancer 61:81-8. 2014
  8. pmc Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group
    Michael R Loken
    HematoLogics Inc, Seattle, WA, USA
    Blood 120:1581-8. 2012
  9. pmc High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group
    Roland B Walter
    Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2 190, Seattle, WA 98109 1024, USA
    J Clin Oncol 28:2831-8. 2010
  10. pmc Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML
    Jessica A Pollard
    Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Blood 119:3705-11. 2012

Detail Information

Publications11

  1. pmc High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: a report from the children's oncology group
    Phoenix A Ho
    Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98103, USA
    Br J Haematol 162:670-7. 2013
    ..EVI1 expression is currently being studied in a larger cohort of patients enrolled on subsequent Children's Oncology Group trials, to determine if EVI1(high) has prognostic value in MLL-rearranged or intermediate-risk subsets...
  2. pmc Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group
    Phoenix A Ho
    Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109, USA
    Blood 113:6558-66. 2009
    ..24, P = .047). As CEBPA mutations are associated with lower relapse rate and improved survival, CEBPA mutation analysis needs to be incorporated into initial screening for risk identification and therapy allocation at diagnosis...
  3. pmc Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric and adult AML: a report from the Children's Oncology Group and SWOG
    Phoenix A Ho
    Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Blood 118:4561-6. 2011
    ..The clinical trials in this study are registered at http://www.clinicaltrials.gov as #NCT000707174 and #NCT00899171...
  4. pmc Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: a report from the Children's Oncology Group
    Phoenix A Ho
    Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Pediatr Blood Cancer 57:204-9. 2011
    ..We previously reported that IDH1 mutations were absent, whereas TET2 mutations were present in 6%, of pediatric AML patients; in the present study, we determined the prevalence of DNMT3A and IDH2 mutations in pediatric AML...
  5. pmc WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric acute myeloid leukemia: a report from the children's oncology group
    Phoenix A Ho
    Fred Hutchinson Cancer Research Center, D2 373, 1100 Fairview Ave N, Seattle, WA 98103, USA
    J Clin Oncol 29:704-11. 2011
    ..To analyze the prevalence and clinical implications of Wilms' tumor 1 (WT1) single nucleotide polymorphism (SNP) rs16754 in the context of other prognostic markers in pediatric acute myeloid leukemia (AML)...
  6. pmc Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group
    Phoenix A Ho
    Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Blood 116:702-10. 2010
    ..The clinical trials are registered at www.clinicaltrials.gov as #NCT00002798 and #NCT00070174...
  7. doi request reprint The prognostic effect of high diagnostic WT1 gene expression in pediatric AML depends on WT1 SNP rs16754 status: report from the Children's Oncology Group
    Phoenix A Ho
    Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington Division of Pediatric Hematology Oncology, Seattle Children s Hospital, University of Washington School of Medicine, Seattle, Washington Children s Oncology Group, Arcadia, California
    Pediatr Blood Cancer 61:81-8. 2014
    ..We examined the clinical correlates of diagnostic WT1 expression within a contemporary COG trial and determined whether its prognostic impact differs between SNP+ and SNP- patients...
  8. pmc Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group
    Michael R Loken
    HematoLogics Inc, Seattle, WA, USA
    Blood 120:1581-8. 2012
    ..001). MDF identifies patients at risk of relapse and poor outcome and can be incorporated into clinical trials for risk-based therapy allocation. This study was registered at www.clinicaltrials.gov as NCT00070174...
  9. pmc High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group
    Roland B Walter
    Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2 190, Seattle, WA 98109 1024, USA
    J Clin Oncol 28:2831-8. 2010
    ..To evaluate the prognostic significance of the integrin cell adhesion molecule very late antigen-4 (VLA-4) in acute myeloid leukemia (AML)...
  10. pmc Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML
    Jessica A Pollard
    Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Blood 119:3705-11. 2012
    ..The correlation between CD33 expression and GO response is under investigation. These studies are registered at www.clinicaltrials.gov as NCT00070174 and NCT00372593...
  11. pmc Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML
    Jessica A Pollard
    Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Blood 115:2372-9. 2010
    ..Two of 4 studies included in this analysis are registered at http://clinicaltrials.gov as NCT00002798 (CCG-2961) and NCT00070174 (COG AAML03P1)...